VA Medical Center, Bronx
The Bronx, New York, 10468, United States
NCT Number: NCT00248807
The purpose of this study is to determine how blood pressure and blood flow are controlled during head-up tilt in a semi-upright position. In this investigation we are studying blood pressure and blood flow to the brain, with and without a medication which lowers blood pressure (Vasotec). We will determine how persons with a spinal cord injury are able to maintain blood flow to the brain (not get dizzy) as they assume a more upright position and their blood pressure decreases.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
The Bronx, New York, 10468, United States
Individuals with tetraplegia lack normal sympathetic nervous system regulation of blood pressure and, therefore, relative hypotension is a common occurrence. This hypotension may be more pronounced with postural stress. Loss in mental acuity and sometimes even consciousness is an associated symptom of postural hypotension in individuals with tetraplegia.
There is some evidence to suggest that although mean arterial blood pressure (MAP) is relatively low in these individuals, middle cerebral arterial blood flow (CBF) may be maintained. Consequently, individuals with chronic tetraplegia often compensate and are stable in the seated upright position.
Autoregulation of CBF has been defined as the stability of cerebral blood flow throughout a range of systemic blood pressures (MAP). This proposal will examine systemic hemodynamics and middle cerebral artery blood flow during HUT with and without Vasotec, an angiotensin II inhibitor. By partially or completely ablating the renin-angiotensin system, which is postulated to play a major role in blood pressure regulation, the potential dissociation between systemic blood pressure and middle cerebral artery blood flow, in individuals with tetraplegia, may be demonstrated. The aim is to determine whether persons with chronic tetraplegia are able to maintain similar CBF, or similar CBF changes, as able-bodied controls despite a greater decrease in MAP to the same hypotensive challenge. The relationship between MAP and CBF has not been defined in this population. Understanding this relationship may lead to improved screening and treatment for prevention of postural hypotension in persons with tetraplegia.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
an angiotensin converting enzyme (ACE) inhibitor given to lower blood pressure (BP) and measure cerebral blood flow (CBF)
45 degree head-up tilt to lower blood pressure and measure cerebral blood flow.
Time frame: acute testing
Systolic blood pressure during head-up tilt in subjects with spinal cord injury without drug intervention
Time frame: acute testing
Measurement of middle cerebral artery blood flow velocity supine and during head-up tilt
VA Office of Research and Development
Fed
Systemic Hemodynamics and Cerebral Blood Flow in Persons With Tetraplegia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07674511
Autonomic Nervous System Diseases, Blood Pressure
West Orange, New Jersey, United States
View Trial DetailsNCT05731986
Acute Spinal Cord Injury, Autonomic Nervous System Diseases
West Orange, New Jersey, United States
View Trial DetailsNCT05725499
Autonomic Nervous System Diseases, Blood Pressure
West Orange, New Jersey, United States
View Trial DetailsNCT02919917
Autonomic Dysreflexia, Autonomic Nervous System Diseases
New York, United States
View Trial Details